Matthew Whitman
Matthew Whitman has made 25 investments in companies such as: ClarVista Medical, Cureatr, andros, Cartiva, Welldoc, HelpAround Medical, Nebula Genomics, Transactis, NeuSpera Medical, Personal Genome Diagnostics, Science Exchange, Coravin, Nuvaira, Delfi Diagnostics, ControlRad Systems, Neotract, Valera Health, ChromaCode, VytronUS, MC10, Fore Biotherapeutics, CVRx, Earlens Corporation, Ivantis, SubjectWell.
Location of Matthew Whitman is United States.The free version of Angel Match provides limited data for Matthew Whitman. Advanced features and premium data such as emails, phone numbers and social media profiles are available only on paid subscription plans.
Matthew Whitman is a Principal and he his investment types are: Venture Capital.
Matthew Whitman focuses investing in industries such as: Analytics, Bioinformatics, Biotechnology, Genetics, Health Diagnostics, Medical, Women Led, Health Care, Hospital, Developer Platform, Medical Device, mHealth, Pharmaceutical, Consulting, Outsourcing, Women Founded, Clinical Trials, Marketplace, Information Technology, Software.
A short brief about investor:
About
Investor type:
Locations:
Past investments
- ClarVista Medical
- Cureatr
- andros
- Cartiva
- Welldoc
- HelpAround Medical
- Nebula Genomics
- Transactis
- NeuSpera Medical
- Personal Genome Diagnostics
- Science Exchange
- Coravin
- Nuvaira
- Delfi Diagnostics
- ControlRad Systems
- Neotract
- Valera Health
- ChromaCode
- VytronUS
- MC10
- Fore Biotherapeutics
- CVRx
- Earlens Corporation
- Ivantis
- SubjectWell